What happened when CMTA-supported scientists at University College London applied long-read sequencing to CMT cases that had no genetic confirmation for years?
CMTA-STAR Partner Applied Therapeutics Presents 24-Month CMT-SORD Data at PNS 2025
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA Strategy To Accelerate Research (CMTA-STAR) Alliance Partner Applied Therapeutics...
Solve-CMT Resource: Addressing the Diagnostic Gap and Drug Target Discovery via Advanced Genomics
CMTA-funded researchers at the GENESIS Project Foundation are using advanced genomics and artificial intelligence to accelerate CMT gene discovery, improve genetic diagnosis, and identify new therapeutic targets.
